Table:
begin	end	state
1	26	cytoplasmic
27	52	transmembrane
53	64	non-cytoplasmic
65	87	transmembrane
88	97	cytoplasmic
98	117	transmembrane
118	122	non-cytoplasmic
123	144	transmembrane
145	163	cytoplasmic
164	187	transmembrane
188	198	non-cytoplasmic
199	221	transmembrane
222	251	cytoplasmic
252	275	transmembrane
276	286	non-cytoplasmic
287	308	transmembrane
309	317	cytoplasmic
318	337	transmembrane
338	342	non-cytoplasmic
343	362	transmembrane
363	382	cytoplasmic
383	405	transmembrane
406	410	non-cytoplasmic
411	432	transmembrane
433	489	cytoplasmic

Input:
>WP_101588932.1 NCBI__GCF_900169175.1:WP_101588932.1
MRGTVTAASAAEPSTARGPFRGKQRVLASAFVGTTIEWYDFYLYGTAAALVFNVQFFPMD
SELGSLLASFATLAVGFFARPLGGIIAGHLGDRVGRKALLVVSLVTMGIASTLIGLMPTY
EAIGWWAAVGLVVLRIFQGLSAGAEWGGSALLSVEHAPVGSRGLFGSFTQIGSAAGMLLA
TSAFFVVQSVLTDEQFAQFGWRIPFVASALLVVIGLWIRLGVSDAPEFLEHKESGNVRKQ
PLWEVVTRHPRVLLVTIGLRLAQNSVYYLITVYMLTYLADQRGDSTAGITAVMIASAIGL
VTGPFWGWVSDRLGRRTVTLGGIIGIGVFGWIFFAFLDNGPLILLPIIVVLGMNLAHDAV
YGPQAAWFAEQFPIEVRYSGVNMGYQLGTVIGGGIMPMVAALLFVAGGSTPWLICAYLTL
LCVLSGIAALAAHDPARAEALARRTDPGPAAAADSAEDPAADPAADSVATEVAAPAAADP
HRPIQETSH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server